Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals (ARMP) Gains from Investment Securities (2016 - 2018)

Historic Gains from Investment Securities for Armata Pharmaceuticals (ARMP) over the last 5 years, with Q4 2018 value amounting to $337000.0.

  • Armata Pharmaceuticals' Gains from Investment Securities changed N/A to $337000.0 in Q4 2018 from the same period last year, while for Dec 2018 it was $347000.0, marking a year-over-year increase of 19837.0%. This contributed to the annual value of $10.8 million for FY2024, which is 29844.44% up from last year.
  • Per Armata Pharmaceuticals' latest filing, its Gains from Investment Securities stood at $337000.0 for Q4 2018.
  • Over the past 5 years, Armata Pharmaceuticals' Gains from Investment Securities peaked at $1.1 million during Q3 2017, and registered a low of -$362750.0 during Q2 2015.
  • For the 4-year period, Armata Pharmaceuticals' Gains from Investment Securities averaged around $200356.1, with its median value being $207208.0 (2016).
  • In the last 5 years, Armata Pharmaceuticals' Gains from Investment Securities skyrocketed by 36303.42% in 2017 and then crashed by 9659.06% in 2018.
  • Armata Pharmaceuticals' Gains from Investment Securities (Quarter) stood at $547181.0 in 2015, then tumbled by 95.17% to $26419.0 in 2016, then soared by 3952.28% to $1.1 million in 2017, then plummeted by 68.52% to $337000.0 in 2018.
  • Its last three reported values are $337000.0 in Q4 2018, $36500.0 for Q3 2018, and $36500.0 during Q2 2018.